OR4D9: Key Protein Involved in The Sense of Smell (G390199)

OR4D9: Key Protein Involved in The Sense of Smell

Olfactory receptor 4D9 (OR4D9) is a protein that is expressed in the human nose and is involved in the sense of smell. It is a member of the olfactory receptor family, which consists of six transmembrane proteins that are involved in the sense of smell. OR4D9 is one of the most well-studied olfactory receptors, and its function in the sense of smell has been extensively investigated.

OR4D9 is a 150-amino acid protein that is composed of a extracellular domain, a transmembrane region, and an intracellular domain. The extracellular domain of OR4D9 consists of a signal transduction domain that is involved in the interaction with G protein-coupled receptors (GPCRs). The transmembrane region of OR4D9 consists of a single transmembrane domain that is involved in the interaction with the intracellular domain of the protein. The intracellular domain of OR4D9 consists of a single transmembrane domain that is involved in the interaction with the intracellular signaling pathway.

OR4D9 is involved in the sense of smell because it is a key protein that is expressed in the human nose. The nose is the only sense organ that is capable of detecting volatile gases, which are the chemicals that are responsible for the sense of smell. OR4D9 is thought to be involved in the detection of these volatile gases, which is the first step in the sense of smell.

OR4D9 has been extensively studied because of its potential as a drug target. Researchers have identified several potential drug targets for OR4D9, including the interaction of OR4D9 with GPCRs and the role of OR4D9 in the sense of smell. These studies have led to the development of several potential new treatments for conditions that are related to the sense of smell, such as depression, anxiety, and cancer.

One of the potential drug targets for OR4D9 is the interaction of OR4D9 with GPCRs. GPCRs are a family of transmembrane proteins that are involved in a wide range of physiological processes, including sensory perception, cardiovascular regulation, and metabolism. OR4D9 has been shown to interact with several different GPCRs, including the GPCR known as GPR82. This interaction between OR4D9 and GPR82 suggests that OR4D9 may be a useful drug target for the treatment of conditions that are related to the sense of smell.

Another potential drug target for OR4D9 is the role of OR4D9 in the sense of smell. OR4D9 is thought to be involved in the detection of volatile gases, which are the chemicals that are responsible for the sense of smell. This suggests that OR4D9 may be a useful drug target for the treatment of conditions that are related to the sense of smell, such as depression or anxiety.

In addition to its potential as a drug target, OR4D9 has also been identified as a potential biomarker for several different diseases. For example, OR4D9 has been shown to be expressed in the brains of individuals with Alzheimer's disease, a condition that is characterized by the progressive loss of memory and cognitive function. This suggests that OR4D9 may be a useful biomarker for the diagnosis and treatment of Alzheimer's disease.

OR4D9 has also been shown to be involved in the regulation of several different physiological processes, including cell signaling and neurotransmission. This suggests that OR4D9 may be a useful target for the treatment of a wide range of conditions, including cancer and depression.

In conclusion, OR4D9 is a protein that is involved in the sense of smell and has been extensively studied for its potential as a drug target and biomarker. Its interaction with GPCRs and its role in the sense of smell make it a promising target for the development of new treatments for a wide range of conditions. Further research is needed to fully understand the functions of OR4D9 and its potential as a drug

Protein Name: Olfactory Receptor Family 4 Subfamily D Member 9

Functions: Odorant receptor

The "OR4D9 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR4D9 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR4E2 | OR4F13P | OR4F15 | OR4F16 | OR4F17 | OR4F21 | OR4F29 | OR4F3 | OR4F4 | OR4F5 | OR4F6 | OR4G3P | OR4K1 | OR4K13 | OR4K14 | OR4K15 | OR4K17 | OR4K2 | OR4K5 | OR4K6P | OR4K7P | OR4L1 | OR4M1 | OR4M2 | OR4M2-OT1 | OR4N2 | OR4N3P | OR4N4 | OR4N5 | OR4P4 | OR4Q3 | OR4S1 | OR4S2 | OR4T1P | OR4V1P | OR4X1 | OR4X2 | OR51A1P | OR51A2 | OR51A3P | OR51A4 | OR51A6P | OR51A7 | OR51B2 | OR51B4 | OR51B5 | OR51B6 | OR51C1P | OR51D1 | OR51E1 | OR51E2 | OR51F1 | OR51F2 | OR51G1 | OR51G2 | OR51H1 | OR51I1 | OR51I2 | OR51J1 | OR51L1 | OR51M1 | OR51Q1 | OR51S1 | OR51T1 | OR51V1 | OR52A1 | OR52A4P | OR52A5 | OR52B2 | OR52B4 | OR52B6 | OR52D1 | OR52E1 | OR52E2 | OR52E4 | OR52E5 | OR52E6 | OR52E8 | OR52H1 | OR52I1 | OR52I2 | OR52J3 | OR52K1 | OR52K2 | OR52K3P | OR52L1 | OR52M1 | OR52N1 | OR52N4 | OR52N5 | OR52R1 | OR52W1 | OR52Z1P | OR56A1 | OR56A3 | OR56A4 | OR56A5 | OR56B1 | OR56B4 | OR5A1